Product Information
PUREVIT DUALFE PLUS CAPSULE is a generic product labeled by PureTek Corporation, priced at $0.3839 per EA under NDC 59088011266. Its NADAC has been published 418 times since Nov 28, 2013.
Strength
10; .8; 15; 53; 1; 53; 1.3; 30; 5; 6; 200; 10; 18.2 mg/1; mg/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1
Manufacturer
PureTek CorporationNDC
59088011266
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Approval Type
Unapproved
On Market Since
6/1/2011
Pharmacological Classes
Price Statistics
The NADAC for PUREVIT DUALFE PLUS CAPSULE has been published 418 times since Nov 28, 2013, and over the history we have for it it has declined 4.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3839 per EA |
|---|---|
| All-time high | $0.6979 (Jul 10, 2019) |
| All-time low | $0.3681 (Aug 21, 2024) |
| 52-week high | $0.4067 |
| 52-week low | $0.3797 |
| Median price | $0.3917 |
| Average price | $0.4287 |
| Largest weekly change | +81.1% (Jul 18, 2018) |
| Weeks tracked | 418 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Ferrous Fumarate, Polysaccharide Iron Complex market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
PureTek Corporation manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ferrous Fumarate, Polysaccharide Iron Complex market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Copper Absorption Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PUREVIT DUALFE PLUS CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for PUREVIT DUALFE PLUS CAPSULE, manufactured by PureTek Corporation, is $0.3839 per EA (NDC 59088011266), effective Sep 30, 2026.
How has the price of PUREVIT DUALFE PLUS CAPSULE changed over time?
Over the history we have for it, the NADAC for PUREVIT DUALFE PLUS CAPSULE has declined 4.3%. It has been tracked across 418 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for PUREVIT DUALFE PLUS CAPSULE?
Since Nov 28, 2013, the NADAC for PUREVIT DUALFE PLUS CAPSULE has ranged from a low of $0.3681 (Aug 21, 2024) to a high of $0.6979 (Jul 10, 2019), with a median of $0.3917 per EA.
Are there cheaper alternatives to PUREVIT DUALFE PLUS CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of PUREVIT DUALFE PLUS CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures PUREVIT DUALFE PLUS CAPSULE?
PUREVIT DUALFE PLUS CAPSULE (NDC 59088011266) is labeled by PureTek Corporation, and CMS classifies it as a generic product.